Skip to main content
. Author manuscript; available in PMC: 2009 Oct 4.
Published in final edited form as: Biochem Biophys Res Commun. 2009 Jul 18;387(4):646–650. doi: 10.1016/j.bbrc.2009.07.080

Table 1.

Potencies of tested compounds at inhibiting MMP-2.

Inhibitor IC50 ± SD (µM)

10 µM ZnSO4 1 nM ZnSO4
PJ-34 56 ± 14 27 ± 10
5-AIQ 102 ± 34 n.d.
3-AB 1760 ± 220* 1000 ± 200
EB-47 >3000 n.d.
o-Phenanthroline 293 ± 14 116 ± 9
Minocycline 57 ± 6 n.d.
Doxycycline 86 ± 13 93 ± 12
GM 6001 0.0018 ± 0.0002* 0.0063 ± 0.0006
*

Statistically significant difference compared to any other inhibitor, P < 0.05, one-way ANOVA with Newman–Keuls post hoc test. Reaction conditions: 50 mM Tris, pH 7.6, containing 10 mM CaCl2, 0.05% Brij-35, 10 µM ZnSO4; 37°C. n.d., not determined.

HHS Vulnerability Disclosure